Jennison Associates LLC Supernus Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$42.7 - $56.55 $420,039 - $556,282	-9,837 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$44.1 - $59.85 $418,509 - $567,976	-9,490 Reduced 49.1%	9,837 $589,000
Q1 2018 Apr 20, 2018	BUY	$37.15 - $46.9 $717,998 - $906,436	19,327 New	19,327 $885,000

281

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.